• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[鼻咽癌的颞下窝入路:手术技巧与初步结果]

[Infratemporal approach in nasopharyngeal cancer: operative technics and initial results].

作者信息

Wolfensberger M, Fisch U

出版信息

HNO. 1985 Jul;33(7):307-10.

PMID:4030414
Abstract

When nasopharyngeal cancer recurs after radiotherapy, and when the dura is not invaded, radical excision is still possible by means of the infratemporal fossa approach (ITFA), developed by the senior author. In an effort to improve the results of radiotherapy, 13 cases of residual or persistent disease were operated on by this approach between 1977 and 1981. Of seven patients with T4 tumours, all died of persistent disease within two to three years. Six patients with T1 or T2 non-keratinizing squamous cell carcinoma are alive two to five years after surgery. Only one patient needed additional surgery for another recurrence. The approach results in a complete conductive hearing loss and permanent anaesthesia of the mandibular nerve. The procedure is safe and well tolerated. Average hospital stay is 14 days. A combination of radiotherapy and surgery is recommended for T1 and T2 carcinoma in order to improve longterm survival rates.

摘要

鼻咽癌放疗后复发且未侵犯硬脑膜时,资深作者所采用的颞下窝入路(ITFA)仍有可能进行根治性切除。为提高放疗效果,1977年至1981年间,采用该入路对13例残留或持续性疾病患者进行了手术。7例T4期肿瘤患者均在两到三年内死于持续性疾病。6例T1或T2期非角化鳞状细胞癌患者术后存活两到五年。仅1例患者因再次复发需要再次手术。该入路会导致完全性传导性听力丧失和下颌神经永久性麻醉。该手术安全且耐受性良好。平均住院时间为14天。对于T1和T2期癌,建议放疗与手术联合应用以提高长期生存率。

相似文献

1
[Infratemporal approach in nasopharyngeal cancer: operative technics and initial results].[鼻咽癌的颞下窝入路:手术技巧与初步结果]
HNO. 1985 Jul;33(7):307-10.
2
Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.T1和T2期鼻咽癌外照射放疗后辅助分次高剂量率腔内近距离放疗
Head Neck. 2004 May;26(5):389-95. doi: 10.1002/hed.10398.
3
Curative surgery for recurrent nasopharyngeal carcinoma via the infratemporal fossa approach.经颞下窝入路治疗复发性鼻咽癌的根治性手术
Arch Otolaryngol Head Neck Surg. 2005 Mar;131(3):213-6. doi: 10.1001/archotol.131.3.213.
4
[Diagnosis and treatment of patients with nasopharyngeal cancer].[鼻咽癌患者的诊断与治疗]
Vestn Otorinolaringol. 2005(3):55-6.
5
[Staging 915 cases of nasopharyngeal carcinoma after simple radical radiotherapy--checkout of Fuzhou staging system (1992)].[915例鼻咽癌单纯根治性放疗后分期——福州分期系统(1992年)的验证]
Ai Zheng. 2005 Oct;24(10):1165-72.
6
Phase II study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma.II期研究:晚期鼻咽癌同步放化疗
J Med Assoc Thai. 1997 Dec;80(12):778-84.
7
Prognostic factors of poorly-differentiated squamous cell carcinoma of the nasopharynx.鼻咽低分化鳞状细胞癌的预后因素
Jpn J Clin Oncol. 1994 Aug;24(4):191-8.
8
Salvage surgery for recurrent nasopharyngeal carcinoma.复发性鼻咽癌的挽救性手术
Laryngoscope. 2000 Sep;110(9):1483-8. doi: 10.1097/00005537-200009000-00014.
9
[Radiotherapy and curietherapy of squamous cell carcinoma of the posterior pharyngeal wall (excluding the nasopharynx)].下咽后壁(不包括鼻咽部)鳞状细胞癌的放射治疗与镭疗法
Bull Cancer Radiother. 1996;83(1):54-9.
10
[Salvage surgery for cervical metastasis from nasopharyngeal carcinoma after radiotherapy].
Zhonghua Er Bi Yan Hou Ke Za Zhi. 1996;31(4):195-7.